Praxis Precision Medicines, Inc.
Praxis Precision Medicines, Inc., a clinical-stage biopharmaceutical company, develops therapies for central nervous system disorders characterized by neuronal imbalance. Its lead product candidates include PRAX-114, an extrasynaptic-preferring GABAA rec…
Biotechnology
US, Boston [HQ]
Revenue Breakdowns
Segment Analysis Beta
The financial segments are sourced from the SEC' 10-K statement.Revenue By Top Segments
Praxis Precision Medicines, Inc. can't present it's sankey chart.
Historical Revenue By Segment
Last 3Y, in million USDPraxis Precision Medicines, Inc. can't present revenue by segment
Get PRO Today
With PRO you can bypass the blur for the segment revenues of Praxis Precision Medicines, Inc..
If you want to see a demo, head over to the financial segments of AAPL